LAURUS LABS LIMITED vs Mankind Pharma Limited
A side-by-side comparison of LAURUS LABS LIMITED (LAURUSLABS) and Mankind Pharma Limited (MANKIND) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, Mankind Pharma Limited leads LAURUSLABS vs MANKIND on 10 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
Valuation
How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
How efficiently each company turns capital and sales into profit. Higher is better.
Growth
Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company has been maintaining a healthy dividend payout of 19.0%"]
- − ["Stock is trading at 16.3 times its book value", "The company has delivered a poor sales growth of 7.19% over past five years.", "Company has a low return on equity of 10.1% over last 3 years.", "Company might be capitalizing the interest cost"]
- + ["Company has reduced debt."]
- − ["Promoter holding has decreased over last 3 years: -3.87%"]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.